WallStreetZenWallStreetZen

NASDAQ: KPRX
Kiora Pharmaceuticals Inc Stock Forecast, Predictions & Price Target

Analyst price target for KPRX

Based on 1 analyst offering 12 month price targets for Kiora Pharmaceuticals Inc.
Min Forecast
$2.00+247.83%
Avg Forecast
$2.00+247.83%
Max Forecast
$2.00+247.83%

Should I buy or sell KPRX stock?

Based on 1 analyst offering ratings for Kiora Pharmaceuticals Inc.
Buy
Strong Buy
0 analysts 0%
Buy
1 analysts 100%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their KPRX stock forecasts and price targets.

KPRX stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2024-03-27

1 of 1

Forecast return on equity

Is KPRX forecast to generate an efficient return?
Company
N/A
Industry
N/A
Market
36.19%

Forecast return on assets

Is KPRX forecast to generate an efficient return on assets?
Company
N/A
Industry
N/A

KPRX revenue forecast

What is KPRX's revenue in the next 1 years based on estimates from 1 analyst?
Avg 1 year Forecast
$16.0M

KPRX vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
KPRX$0.58$2.00+247.83%Buy
IMRN$2.65N/AN/A
COEP$0.42N/AN/A
TRAW$0.71N/AN/A
IMNN$1.59$13.00+717.61%Buy

Kiora Pharmaceuticals Stock Forecast FAQ

Is Kiora Pharmaceuticals Stock a good buy in 2024, according to Wall Street analysts?

The consensus among 1 Wall Street analyst covering (NASDAQ: KPRX) stock is to Buy KPRX stock.

Out of 1 analyst, 0 (0%) are recommending KPRX as a Strong Buy, 1 (100%) are recommending KPRX as a Buy, 0 (0%) are recommending KPRX as a Hold, 0 (0%) are recommending KPRX as a Sell, and 0 (0%) are recommending KPRX as a Strong Sell.

If you're new to stock investing, here's how to buy Kiora Pharmaceuticals stock.

What is KPRX's revenue growth forecast for 2024-2024?

(NASDAQ: KPRX) Kiora Pharmaceuticals's forecast annual revenue growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 38.74%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 10.34%.

Kiora Pharmaceuticals's revenue in 2024 is $0.

In 2024, KPRX is forecast to generate $420,099,152 in revenue, with the lowest revenue forecast at $420,099,152 and the highest revenue forecast at $420,099,152.

What is KPRX's forecast return on assets (ROA) for 2024-2027?

(NASDAQ: KPRX) forecast ROA is N/A, which is lower than the forecast US Biotechnology industry average of N/A.

What is KPRX's Price Target?

According to 1 Wall Street analyst that have issued a 1 year KPRX price target, the average KPRX price target is $2.00, with the highest KPRX stock price forecast at $2.00 and the lowest KPRX stock price forecast at $2.00.

The Wall Street analyst predicted that Kiora Pharmaceuticals's share price could reach $2.00 by Mar 27, 2025. The average Kiora Pharmaceuticals stock price prediction forecasts a potential upside of 247.83% from the current KPRX share price of $0.58.

What is KPRX's forecast return on equity (ROE) for 2024-2027?

(NASDAQ: KPRX) forecast ROE is N/A, which is considered weak.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.